North America Histopathology Services Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type of Examination (Surgical Specimen, Breast Biopsy, Lung Biopsy, Renal Biopsy, Gastrointestinal Biopsy, Pancreatic Biopsy, Skin Tissue Biopsy, Testicular Biopsy, and Others) and End User (Diagnostic Laboratories & Reference Laboratories, Research Institutes, and Others)
Market Introduction
Histopathology services are used in the examination of biological tissues for the diagnosis of diseases. The procedure includes microscopic examination of tissues. With the help of imaging techniques biopsy tissues can now be obtained from certain inaccessible sites such as pancreas and the peritoneum.
Get more information on this report :
Market Overview and Dynamics
The North America histopathology services market is expected to reach US$ 13,902.74 million by 2028 from US$ 9,283.83 million in 2021; it is estimated to grow at a CAGR of 5.9% from 2021 to 2028. Factors such as rising demand for biologics and increasing prevalence of chronic diseases drive the market growth. However, limitations associated with histopathology and immunohistochemistry hinder the North America histopathology services market growth.
The histopathology market for biologics is growing at an unprecedented rate owing to expansion of biologics pipeline, increase in manufacturing complexity, and shift in the focus of companies toward core activities. A significant boom has been witnessed in the manufacturing of biologics. There is pressing need of scaling up the production once novel technologies get approval from the domestics and international approving bodies. The competition within the biopharmaceutical sector is becoming fierce with more biological products and biosimilars being introduced in the market. Biologics manufacturers strive to keep manufacturing costs low, deliver high-quality drugs, improve process efficiency, and accelerate market entry. Inputs from expert histopathologists have been playing a significant role in the understanding of tumor biology as well as in the pathogenic mechanism of various microorganisms. These findings and inferences are utilized by dedicated organizations offering histopathological services. According to the Food and Drug Administration, as of September 2019, there were more than 350 biologics commercially available in the US biopharmaceutical market. Clinical trials and drug discovery procedures of these drugs are based on intrinsic histopathological studies conducted using high-tech equipment, under expert supervision. Thus, the increasing number of biologic treatment in the pipeline that require histopathological interventions is propelling the growth of the North America histopathology services market. Further, the escalating incidence of chronic diseases, such as cardiovascular disorders, neurological disorders, autoimmune disorders, and cancer, is a leading causes of mortalities and disabilities worldwide. Researchers and therapists are exploring therapies for treating these diseases; they conduct detailed histopathological analysis to understand the pathophysiology of these diseases for designing therapies, which is contributing to the histopathology services market growth in North America.
The COVID-19 pandemic has impacted every aspect of the diagnostics industry in North America, including histopathology. In the last few months, the number of patient visits to hospitals has reduced significantly, despite emergency and OPD services being available in hospitals. Due to lockdowns enforced in many countries, the number of elective and cancer surgeries have reduced significantly. Moreover, due to the robust increase in the incidence of COVID- 19, pathology laboratories are now prioritizing and focusing on COVID-19 diagnosis. A rapid increase in the number of infected patients in the US and Canada is hampering the growth of the histopathology services market performance in the region.
Key Market Segments
The North America histopathology services market, by type of examination, is segmented into surgical specimen, breast biopsy, lung biopsy, renal biopsy, gastrointestinal biopsy, pancreatic biopsy, skin tissue biopsy, testicular biopsy, and others. In 2021, the surgical specimen segment is likely to hold the largest share of the market, and it is further expected to register the highest CAGR during 2021–2028.
Based on end user, the North America histopathology services market is segmented into diagnostic laboratories and reference laboratories, research institutes, and others. The diagnostic laboratories and reference laboratories segment is likely to hold the largest share of the market in 2021, and it is anticipated to register the highest CAGR during the forecast period.
Major Sources and Companies Listed
A few of the primary and secondary sources associated with this report on the North America histopathology services market are the Centers for Disease Control and Prevention (CDC), Center for Drug Evaluation and Research (CDER), and Food and Drug Administration (FDA).
Reasons to buy the report
- Determine prospective investment areas based on a detailed trend analysis of North America histopathology services market over the next years.
- Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
- Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
- Identify the major channels driving the North America histopathology services market, providing a clear picture of future opportunities that will help analyze, resulting in revenue expansion.
- Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America histopathology services market.
NORTH AMERICA HISTOPATHOLOGY SERVICES MARKET SEGMENTATION
By Type of Examination
- Surgical Specimen
- Breast Biopsy
- Lung Biopsy
- Renal Biopsy
- Gastrointestinal Biopsy
- Pancreatic Biopsy
- Skin Tissue Biopsy
- Testicular Biopsy
- Others
By End User
- Diagnostic Laboratories & Reference Laboratories
- Research Institutes
- Others
By Country
- US
- Canada
- Mexico
Company Profiles
- Sonic Healthcare Limited
- Laboratory Corporation of America Holdings
- TPL Path Labs
- Cureline Global Translational CRO
- Targos
- Experimental Pathology Laboratories Inc (EPL)
- CHARLES RIVER LABORATORIES, INC.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Histopathology Services Market – By Type of Examination
1.3.2 North America Histopathology Services Market – By End User
1.3.3 North America Histopathology Services Market – By Country
2. Histopathology Services Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Histopathology Services Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.3 Expert Opinions
5. Histopathology Services Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Demand for Biologics
5.1.2 Increasing Prevalence of Chronic Diseases
5.2 Market Restraints
5.2.1 Limitations Associated with Histopathology and Immunohistochemistry
5.3 Future Trends
5.3.1 Strategic Alliances Among Market Players
5.4 Impact Analysis
6. Histopathology Services Market – North America Analysis
6.1 North America Histopathology Services Market Revenue Forecast and Analysis
7. Histopathology Services Market Analysis – By Type of Examination
7.1 Overview
7.2 Histopathology Services Market Revenue Share, by Type of Examination (2021 and 2028)
7.3 Surgical Specimen
7.3.1 Overview
7.3.2 Surgical Specimen: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Breast Biopsy
7.4.1 Overview
7.4.2 Breast Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Lung Biopsy
7.5.1 Overview
7.5.2 Lung Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Renal Biopsy
7.6.1 Overview
7.6.2 Renal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Gastrointestinal Biopsy
7.7.1 Overview
7.7.2 Gastrointestinal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.8 Pancreatic Biopsy
7.8.1 Overview
7.8.2 Pancreatic Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.9 Skin Tissue Biopsy
7.9.1 Overview
7.9.2 Skin Tissue Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.10 Testicular Biopsy
7.10.1 Overview
7.10.2 Testicular Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
7.11 Others
7.11.1 Overview
7.11.2 Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8. Histopathology Services Market Analysis – By End User
8.1 Overview
8.2 Histopathology Services Market Share, by End User, 2021 and 2028, (%)
8.3 Diagnostic Laboratories and Reference Laboratories
8.3.1 Overview
8.3.2 Diagnostic Laboratories and Reference Laboratories: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Research Institutes
8.4.1 Overview
8.4.2 Research Institutes: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
9. Histopathology Services Market – North America Analysis
9.1 North America: Histopathology Services Market
9.1.1 Overview
9.1.2 North America: Histopathology Services Market, by Country, 2021 & 2028 (%)
9.1.3 US: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.1 US: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.3.2 US: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.3.3 US: Histopathology Services, Market, by End User, 2019-2028 (USD Million)
9.1.4 Canada: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.4.1 Canada: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.4.2 Canada: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.4.3 Canada: Histopathology Services Market, by End User, 2019-2028 (USD Million)
9.1.5 Mexico: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.1 Mexico: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
9.1.5.2 Mexico: Histopathology Services Market, by Type of Examination, 2019-2028 (USD Million)
9.1.5.3 Mexico: Histopathology Services, Market, by End User, 2019-2028 (USD Million)
10. Impact of COVID-19 Pandemic on North America Histopathology Services Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Developments by Key Market Players
11.2.1 Overview
12. Company Profiles
12.1 Sonic Healthcare Limited
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Laboratory Corporation of America Holdings
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 TPL Path Labs
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Cureline Global Translational CRO
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Targos
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Experimental Pathology Laboratories Inc (EPL)
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 CHARLES RIVER LABORATORIES, INC.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Estimated Number of New Cancer Cases and Deaths, US, 2020
Table 2. US Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 3. US Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. Canada Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 6. Mexico Incidence, Mortality and Prevalence by Cancer Site in 2018
Table 7. Mexico Histopathology Services Market, by Type of Examination– Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Histopathology Services Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Developments Done by Key Players
Table 10. Glossary of Terms, Histopathology Services Market
LIST OF FIGURES
Figure 1. Histopathology Services Market Segmentation
Figure 2. Histopathology Services Market Segmentation, By Country
Figure 3. Histopathology Services Market Overview
Figure 4. Surgical Specimen Segment Held Largest Share of Histopathology Services Market
Figure 5. North America Histopathology Services Market – Leading Country Markets (US$ Million)
Figure 6. North America PEST Analysis
Figure 7. Histopathology Services Market Impact Analysis of Drivers and Restraints
Figure 8. North America Histopathology Services Market – Revenue Forecast and Analysis – 2020- 2028
Figure 9. Histopathology Services Market Revenue Share, by Type of Examination (2021 and 2028)
Figure 10. Surgical Specimen: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Breast Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Lung Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Renal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Gastrointestinal Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Pancreatic Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Skin Tissue Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Testicular Biopsy: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Histopathology Services Market Share, by End User, 2021 and 2028 (%)
Figure 20. Diagnostic Laboratories and Reference Laboratories: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Research Institutes: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Histopathology Services Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. North America: Market, by Key Country – Revenue (2021) (USD Million)
Figure 24. North America: Histopathology Services Market, by Country, 2021 & 2028 (%)
Figure 25. US: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 26. Canada: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Mexico: Histopathology Services Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Impact of COVID-19 Pandemic in North American Country Markets
- Sonic Healthcare Limited
- Laboratory Corporation of America Holdings
- TPL Path Labs
- Cureline Global Translational CRO
- Targos
- Experimental Pathology Laboratories Inc (EPL)
- CHARLES RIVER LABORATORIES, INC.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America histopathology services market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the North America histopathology services market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.